MSRB2 and Parkinson disease: Also consistent with the association of oxidative stress induced mitochondrial damage and apoptosis with Parkinson's disease, levels of the oxidative protective protein methionine sulfoxide reductase type 2 (Msrb2) was recently shown to be reduced in platelets of Parkinson's disease patients leading to increased platelet apoptosis (119).